| Medical and Health Sciences | Lifetime | 896 | CA 51 | 99.96 |
| Medical and Health Sciences | 2021-2025 | 642 | CA 24 | 99.86 |
| Infectious Diseases | Lifetime | 16 | CA 1 | 99.93 |
| Epidemiology | Lifetime | 366 | CA 20 | 99.56 |
| Infectious Diseases | 2021-2025 | 68 | CA 1 | 98.98 |
| Public, Environmental and Occupational Health | 2021-2025 | 182 | CA 12 | 98.47 |
| General Health Professions | 2021-2025 | 511 | CA 48 | 95.95 |
| Infectious Diseases and Tuberculosis | Lifetime | 1 | CA 1 | 99.91 |
| Tuberculosis Research and Epidemiology | Lifetime | 4 | CA 1 | 99.95 |
| Mycobacterium research and diagnosis | Lifetime | 5 | CA 1 | 99.89 |
| Diagnosis and treatment of tuberculosis | Lifetime | 3 | CA 1 | 99.86 |
| Pneumonia and Respiratory Infections | Lifetime | 19 | CA 2 | 99.82 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 24 | CA 1 | 99.71 |
| Global Health and Surgery | Lifetime | 12 | CA 1 | 98.93 |
| COVID-19 diagnosis using AI | Lifetime | 41 | CA 1 | 98.64 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 791 | CA 26 | 97.02 |
| Global Public Health Policies and Epidemiology | Lifetime | 413 | CA 21 | 95.61 |
| SARS-CoV-2 detection and testing | Lifetime | 388 | CA 18 | 94.16 |
| Healthcare Systems and Reforms | Lifetime | 399 | CA 14 | 95.72 |
| Antibiotic Use and Resistance | Lifetime | 892 | CA 38 | 95.10 |
| Viral Infections and Outbreaks Research | Lifetime | 977 | CA 28 | 92.89 |
| Biosimilars and Bioanalytical Methods | Lifetime | 832 | CA 29 | 89.78 |
| HIV/AIDS Impact and Responses | Lifetime | 751 | CA 20 | 88.27 |
| Health and Conflict Studies | Lifetime | 476 | CA 29 | 85.26 |
| Biotechnology and Related Fields | Lifetime | 762 | CA 41 | 75.93 |
| Global Health and Epidemiology | Lifetime | 484 | CA 14 | 71.63 |
| Tuberculosis Research and Epidemiology | 2021-2025 | 7 | CA 1 | 99.48 |
| Global Health and Surgery | 2021-2025 | 3 | CA 2 | 99.34 |
| COVID-19 diagnosis using AI | 2021-2025 | 111 | CA 3 | 97.01 |
| Healthcare cost, quality, practices | 2021-2025 | 47 | CA 5 | 95.29 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 113 | CA 5 | 93.35 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 195 | CA 9 | 91.46 |
| Pneumonia and Respiratory Infections | 2021-2025 | 420 | CA 15 | 92.46 |
| Antibiotic Use and Resistance | 2021-2025 | 422 | CA 13 | 91.98 |
| Global Health Workforce Issues | 2021-2025 | 297 | CA 27 | 86.13 |
| Healthcare Systems and Reforms | 2021-2025 | 679 | CA 16 | 80.18 |
| Viral Infections and Outbreaks Research | 2021-2025 | 973 | CA 28 | 77.34 |
| Infectious Diseases and Tuberculosis | 2021-2025 | 733 | CA 18 | 73.85 |
| Immune responses and vaccinations | 2021-2025 | 422 | CA 21 | 70.93 |
